Pliant Therapeutics (PLRX) Earnings Date & Reports

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PLRX is expected to report earnings to rise 15.94% to -37 cents per share on August 10

Pliant Therapeutics PLRX Stock Earnings Reports

Q2'26

Est.

$-0.37

Q1'26

Beat

by $0.03

Q4'25

Beat

by $0.01

Q3'25

Beat

by $0.13

Q2'25

Missed

by $0.05

The last earnings report on May 11 showed earnings per share of -31 cents, beating the estimate of -35 cents. With 425.51K shares outstanding, the current market capitalization sits at 71.83M.

View a ticker or compare two or three

Compare

PLRX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for PLRX